A. Assandri

发表

Double‐blind, placebo‐controlled, multiple‐ascending‐dose study on the effects of ABIO‐08/01, a novel anxiolytic drug, on perception and cognition, utilizing event‐related potential mapping and low‐resolution brain electromagnetic tomography

P. Anderer, B. Saletu, M. Wolzt, 2008, Human psychopharmacology.

Local tolerability and pharmacokinetic profile of a new transdermal delivery system, diclofenac hydroxyethylpyrrolidine plaster.

C. Giachetti, A. Assandri, S. Canali, 1993, Drugs under experimental and clinical research.

The Immunosuppressor ST1959, a 3,5-Diaryl-S-Triazole Derivative, Inhibits T Cell Activation by Reducing NFAT Nuclear Residency

V. Ruggiero, R. De Santis, A. Assandri, 2009, International journal of immunopathology and pharmacology.

On the mode of action of a new contragestational agent (DL 111-IT).

A. Assandri, D. Barone, F. Luzzani, 1986, Contraception.

MSD, ECD and NPD performances compared in the assay of six non steroidal anti-inflammatory drugs in plasma samples

C. Giachetti, A. Assandri, G. Zanolo, 1994 .

Characterization of [3 H]zetidoline binding to rat striatal membranes

G. Tarzia, A. Assandri, D. Barone, 1985, The Journal of pharmacy and pharmacology.

Disposition and Metabolism of Safinamide, a Novel Drug for Parkinson's Disease, in Healthy Male Volunteers

M. Brunner, P. Ventura, A. Assandri, 2013, Pharmacology.

Binding of teicoplanin to human serum albumin

A. Bernareggi, A. Assandri, 2004, European Journal of Clinical Pharmacology.

Pharmacokinetics and metabolism of deflazacort in the rat, dog, monkey and man.

G. Buniva, A. Assandri, E. Martinelli, 1984, Advances in experimental medicine and biology.

In vivo stereospecific [3H]spiperone binding in rat brain: characteristics, regional distribution, kinetics and pharmacological properties.

S. Garattini, A. Assandri, T. Mennini, 1985, European journal of pharmacology.

Metabolism of deflazacort in the rat, dog and man.

A. Assandri, E. Martinelli, P. Ferrari, 1979, Drug metabolism and disposition: the biological fate of chemicals.

Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride. II: Studies in the dog.

G. Tarzia, A. Assandri, L. Zerilli, 1985, Xenobiotica; the fate of foreign compounds in biological systems.

Determination of cyclic butylboronate esters of some 1,2- and 2,3-diols in plasma by high-resolution gas chromatography/mass spectrometry.

C. Giachetti, A. Assandri, P. Poletti, 1989, Biomedical & environmental mass spectrometry.

Systemic Absorption of Rifamycin SV MMX Administered as Modified-Release Tablets in Healthy Volunteers

A. Assandri, L. Moro, M. Dröge, 2011, Antimicrobial Agents and Chemotherapy.

Gas chromatographic-mass spectrometric determination of ethyl carbamate as the xanthylamide derivative in Italian aqua vitae (grappa) samples.

C. Giachetti, A. Assandri, G. Zanolo, 1991, Journal of chromatography.

Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry

B. Saletu, P. Anderer, B. Saletu, 2005, European Neuropsychopharmacology.

Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry

H. Semlitsch, P. Anderer, B. Saletu, 2002, Journal of Neural Transmission.

Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping.

H. Semlitsch, P. Anderer, B. Saletu, 2002, The international journal of neuropsychopharmacology.

Pharmacokinetics and metabolism of tomoxiprole, a new analgesic antiinflammatory agent, in the rat

A. Bernareggi, A. Assandri, A. Ripamonti, 1985, European Journal of Drug Metabolism and Pharmacokinetics.

Metabolic oxidation of the pyrrole ring: structure and origin of some urinary metabolites of the anti-hypertensive pyrrolylpyridazinamine, mopidralazine. III: Studies with the 13C-labelled drug.

G. Tarzia, A. Assandri, L. Zerilli, 1987, Xenobiotica; the fate of foreign compounds in biological systems.

Pharmacokinetics of [14C]teicoplanin in male rats after single intravenous dose

A. Bernareggi, A. Assandri, L. Cavenaghi, 1986, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and metabolism of N-(2-hydroxyethyl)-2,5-[14C]-pyrrolidine (HEP, Epolamine) in male healthy volunteers

C. Giachetti, B. Palumbo, A. Assandri, 1996, European Journal of Drug Metabolism and Pharmacokinetics.

Teicoplanin metabolism in rats.

A. Bernareggi, A. Assandri, L. Cavenaghi, 1989, Antimicrobial Agents and Chemotherapy.

Metabolism of 5-isopropyl-1-methyl-2-nitro-1H-imidazole. Identification of some urinary metabolites in the dog.

A. Assandri, E. Martinelli, L. Zerilli, 1978, Drug metabolism and disposition: the biological fate of chemicals.

Disposition and metabolism of a new steroidal anti-inflammatory agent, deflazacort, in cynomolgus monkeys.

A. Assandri, L. Zerilli, P. Ferrari, 1983, Xenobiotica; the fate of foreign compounds in biological systems.

Pharmacokinetics of rifapentine, a new long lasting rifamycin, in the rat, the mouse and the rabbit.

A. Assandri, T. Cristina, B. Ratti, 1984, The Journal of antibiotics.

Physiological disposition of a series of rifamycins in rat: a comparative study.

A. Assandri, T. Cristina, L. Moro, 1978, The Journal of antibiotics.

Disposition of premazepam, an anti-anxiety pyrrolodiazepine, in the cynomolgus monkey

G. Tarzia, A. Bernareggi, A. Assandri, 1986, European Journal of Drug Metabolism and Pharmacokinetics.

Contragestational profile of the tumor-inhibiting agent,L-alanosine, in the rat and the hamster

A. Assandri, D. Barone, M. Grandi, 2004, Cancer Chemotherapy and Pharmacology.

Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteers

B. Jansen, V. Wacheck, A. Assandri, 2000, European Journal of Clinical Pharmacology.

Clinical Study of the Therapeutic Efficacy and Safety of Emedastine Difumarate versus Terfenadine in the Treatment of Seasonal Allergic Rhinitis

A. Assandri, M. Radicioni, J. Hartwig, 2004, Arzneimittelforschung.

Clinical Study of the Therapeutic Efficacy and Safety of Emedastine Difumarate versus Cetirizine in the Treatment of Seasonal Allergic Rhinitis

F. Horak, A. Assandri, R. Zieglmayer, 2004, Arzneimittelforschung.

Pharmacokinetic and mass balance study of unlabelled and 14 C-labelled emedastine difumarate in healthy volunteers

H. Eichler, M. Brunner, A. Assandri, 2002, Xenobiotica; the fate of foreign compounds in biological systems.

Emedastine-ketoconazole: pharmacokinetic and pharmacodynamic interactions in healthy volunteers.

U. Herranz, A. Assandri, A. Rusca, 2001, International journal of clinical pharmacology and therapeutics.

Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairment

H. Eichler, C. Schrolnberger, U. Herranz, 2001, European Journal of Clinical Pharmacology.

Electrophysiological neuroimaging of the central effects of S-adenosyl-l-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography

P. Anderer, B. Saletu, G. Saletu-Zyhlarz, 2002 .

Immunological profile of DL111-IT, a new immunosuppressant agent.

A. Assandri, G. Galliani, S. Filippeschi, 1985, Immunopharmacology.

Effect of deflazacort, a glucocorticoid with bone-sparing properties, on mixed lymphocyte response and skin graft rejection.

A. Assandri, T. Cristina, G. Galliani, 1984, Transplantation.

Metabolic pathways of the contragestational agent, 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole (DL 111-IT), in the rat.

A. Assandri, L. Zerilli, P. Ferrari, 1984, Xenobiotica; the fate of foreign compounds in biological systems.

DL 111, a new non-hormonal antifertility agent: contragestational and kinetic profile in baboons.

L. Lerner, A. Assandri, A. Grant, 1982, Contraception.

A new non-hormonal pregnancy-terminating agent.

A. Soffientini, C. Oldani, A. Assandri, 1981, Contraception.

Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Study on the Pharmacodynamics of ABIO-08/01, a New CNS Drug with Potential Anxiolytic Activity

Michael Wolzt, Bernd Saletu, Peter Anderer, 2009, Neuropsychobiology.

Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Study on the Pharmacodynamics of ABIO-08/01, a New CNS Drug with Potential Anxiolytic Activity

Michael Wolzt, Bernd Saletu, Peter Anderer, 2009, Neuropsychobiology.

Influence of metabolism on the activity of a new anti-fertility agent, 2-(3-ethoxyphenyl)-5,6-dihydro-s-triazolo [5,1-a]isoquinoline (DL 204-IT), in the rat and the hamster.

A. Assandri, E. Martinelli, P. Ferrari, 1981, Arzneimittel-Forschung.

Gas chromatography-mass spectrometry determination of etodolac in human plasma following single epicutaneous administration.

C. Giachetti, A. Assandri, G. Zanolo, 1994, Biomedical chromatography : BMC.

Increased oral activity of a new class of non-hormonal pregnancy terminating agents.

A. Assandri, T. Cristina, G. Galliani, 1982, Journal of Pharmacobio-Dynamics.

2-(1,1'-Biphenyl-4-yl)- 1,2,4-triazole[5,1-a] isoquinoline (L 14105), a potential orally active contragestational agent for the bitch: studies in the rat, hamster and dog.

G. Tarzia, A. Assandri, G. Galliani, 1986, Journal of veterinary pharmacology and therapeutics.

DL 717‐IT: a non‐hormonal agent for the control of fertility in the bitch

A. Assandri, G. Galliani, C. Caramel, 1984 .

A NEW CLASS OF NON-HORMONAL CONTRAGESTATIONAL AGENTS: PHARMACODYNAMIC-PHARMACOKINETIC RELATIONSHIPS

A. Assandri, G. Galliani, A. Omodei-sale, 1982, Quarterly reviews on drug metabolism and drug interactions.

Protein binding of rifampicin to bovine serum albumin as measured by gel filtration.

G. Semenza, A. Assandri, 1977, Journal of chromatography.

Studies of binding C3-substitute rifamycins to human and bovine serum albumin.

A. Assandri, M. Berti, A. Perazzi, 1977, The Journal of antibiotics.

Protein binding of a series of rifamycins to bovine serum albumin as measured by the "two-phase partition" technique.

A. Assandri, L. Moro, 1977, Journal of Chromatography A.

Interaction of diftalone and some of its metabolites with human serum proteins.

A. Assandri, A. Zerial, A. Perazzi, 1975, Biochemical pharmacology.

Gas chromatographic determination of some glycol ethers and glycol ether acetates by FID, O‐FID, and MS detection. Preliminary applications in simultaneous monitoring of these chemicals in biological matrices

C. Giachetti, A. Assandri, G. Zanolo, 1996 .